ADVM-022 Intravitreal Gene Therapy for Wet AMD
Public ClinicalTrials.gov record NCT03748784. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
An Open Label Phase 1 Study of ADVM-022 (AAV.7m8-aflibercept) in Neovascular (Wet) Age-Related Macular Degeneration
Study identification
- NCT ID
- NCT03748784
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 1
- Lead sponsor
- Adverum Biotechnologies, Inc.
- Industry
- Enrollment
- 30 participants
Conditions and interventions
Interventions
- ADVM-022 Biological
Biological
Eligibility (public fields only)
- Age range
- 50 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 13, 2018
- Primary completion
- Jun 21, 2022
- Completion
- Jun 21, 2022
- Last update posted
- Aug 7, 2023
2018 – 2022
United States locations
- U.S. sites
- 11
- U.S. states
- 8
- U.S. cities
- 11
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Adverum Clinical Site | Bakersfield | California | 93309 | — |
| Adverum Clinical Site | Beverly Hills | California | 90211 | — |
| Adverum Clinical Site | Golden | Colorado | 80401 | — |
| Adverum Clinical Site | Deerfield Beach | Florida | 33064 | — |
| Adverum Clinical Site | Reno | Nevada | 89502 | — |
| Adverum Clinical Site | Philadelphia | Pennsylvania | 19107 | — |
| Adverum Clinical Site | West Columbia | South Carolina | 29169 | — |
| Adverum Clinical Site | Nashville | Tennessee | 37203 | — |
| Adverum Clinical Site | Abilene | Texas | 79606 | — |
| Adverum Clinical Site | Houston | Texas | 77030 | — |
| Adverum Clinical Site | The Woodlands | Texas | 77384 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03748784, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 7, 2023 · Synced Jun 26, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT03748784 live on ClinicalTrials.gov.